Lipid-modifying drugs for secondary prevention of atherosclerotic cardiovascular events

Statin therapy reduces cardiovascular morbidity and mortality in patients with established ASCVD, and should be given irrespective of the patient’s lipid levelsMach, 2020. Use high-intensity statin therapy, as lower lipid targets are used in patients with established ASCVD.

Additional lipid-modifying drugs may be required if lipid targets are not reached with a statin alone.

See Lipid modification for information about lipid targets and lipid-modifying drugs.